Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Parkinson Disease | 30 | 2023 | 2863 | 1.720 |
Why?
|
Alzheimer Disease | 34 | 2024 | 8543 | 0.720 |
Why?
|
Lewy Body Disease | 7 | 2024 | 252 | 0.700 |
Why?
|
Amyloid beta-Peptides | 16 | 2024 | 3826 | 0.650 |
Why?
|
Perimenopause | 2 | 2021 | 141 | 0.640 |
Why?
|
Vasomotor System | 1 | 2019 | 207 | 0.620 |
Why?
|
alpha-Synuclein | 6 | 2017 | 749 | 0.580 |
Why?
|
Activities of Daily Living | 12 | 2023 | 2414 | 0.530 |
Why?
|
Cultural Diversity | 2 | 2020 | 365 | 0.480 |
Why?
|
Nasal Obstruction | 3 | 2021 | 159 | 0.450 |
Why?
|
Disease Progression | 22 | 2023 | 13464 | 0.450 |
Why?
|
Rhinoplasty | 3 | 2021 | 238 | 0.410 |
Why?
|
Cholecalciferol | 2 | 2014 | 549 | 0.400 |
Why?
|
Calciphylaxis | 2 | 2024 | 130 | 0.400 |
Why?
|
Longitudinal Studies | 29 | 2024 | 14478 | 0.380 |
Why?
|
Apathy | 4 | 2017 | 107 | 0.370 |
Why?
|
Cognition Disorders | 13 | 2021 | 3975 | 0.360 |
Why?
|
Neuropsychological Tests | 25 | 2024 | 7024 | 0.360 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 2 | 2024 | 200 | 0.350 |
Why?
|
Glucosylceramidase | 3 | 2021 | 125 | 0.340 |
Why?
|
tau Proteins | 9 | 2024 | 2085 | 0.340 |
Why?
|
Memory | 7 | 2023 | 2179 | 0.330 |
Why?
|
Nasal Septum | 2 | 2020 | 130 | 0.310 |
Why?
|
Vitamin D Deficiency | 2 | 2014 | 1377 | 0.290 |
Why?
|
Migraine Disorders | 1 | 2019 | 1694 | 0.270 |
Why?
|
Aging | 13 | 2020 | 8650 | 0.270 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 2 | 2021 | 415 | 0.260 |
Why?
|
Aged | 76 | 2024 | 167889 | 0.260 |
Why?
|
Positron-Emission Tomography | 13 | 2024 | 6457 | 0.250 |
Why?
|
Humans | 139 | 2024 | 757650 | 0.250 |
Why?
|
Caregivers | 3 | 2022 | 2224 | 0.250 |
Why?
|
Psychiatric Status Rating Scales | 10 | 2018 | 6012 | 0.250 |
Why?
|
Female | 102 | 2024 | 389985 | 0.240 |
Why?
|
Statistics as Topic | 1 | 2011 | 2357 | 0.240 |
Why?
|
Cognition | 11 | 2023 | 6955 | 0.240 |
Why?
|
Hippocampus | 5 | 2024 | 3739 | 0.230 |
Why?
|
Research Design | 3 | 2023 | 6151 | 0.230 |
Why?
|
Gangliosidoses, GM2 | 1 | 2023 | 20 | 0.230 |
Why?
|
Infarction, Middle Cerebral Artery | 2 | 2024 | 485 | 0.220 |
Why?
|
Male | 96 | 2024 | 358227 | 0.220 |
Why?
|
Lasers | 2 | 2018 | 951 | 0.220 |
Why?
|
Brain | 13 | 2020 | 26950 | 0.220 |
Why?
|
Subarachnoid Hemorrhage | 2 | 2021 | 1031 | 0.220 |
Why?
|
Social Participation | 3 | 2021 | 182 | 0.220 |
Why?
|
Dendritic Cells | 3 | 2018 | 2723 | 0.210 |
Why?
|
Haptoglobins | 1 | 2024 | 167 | 0.210 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2023 | 10135 | 0.210 |
Why?
|
Hyperbaric Oxygenation | 1 | 2023 | 165 | 0.200 |
Why?
|
Aged, 80 and over | 38 | 2024 | 58559 | 0.200 |
Why?
|
Cross-Sectional Studies | 25 | 2024 | 25931 | 0.190 |
Why?
|
Iodine | 1 | 2024 | 286 | 0.190 |
Why?
|
Depression | 8 | 2021 | 8052 | 0.190 |
Why?
|
Cyclonic Storms | 1 | 2023 | 116 | 0.190 |
Why?
|
Carbolines | 3 | 2021 | 286 | 0.190 |
Why?
|
Dementia | 5 | 2017 | 2649 | 0.190 |
Why?
|
Cerebral Cortex | 6 | 2021 | 5756 | 0.190 |
Why?
|
Dacryocystitis | 1 | 2021 | 68 | 0.180 |
Why?
|
Middle Aged | 55 | 2024 | 219219 | 0.180 |
Why?
|
Basal Ganglia Diseases | 1 | 2021 | 145 | 0.180 |
Why?
|
Skin | 3 | 2018 | 4464 | 0.180 |
Why?
|
Anesthetics, Dissociative | 1 | 2020 | 80 | 0.180 |
Why?
|
Stroke | 5 | 2024 | 9695 | 0.180 |
Why?
|
Delayed Diagnosis | 1 | 2024 | 462 | 0.170 |
Why?
|
Brain Mapping | 3 | 2014 | 6571 | 0.170 |
Why?
|
Putamen | 1 | 2021 | 291 | 0.170 |
Why?
|
Vaccines | 2 | 2018 | 832 | 0.170 |
Why?
|
Erythrocytes, Abnormal | 1 | 2020 | 121 | 0.170 |
Why?
|
Parahippocampal Gyrus | 1 | 2020 | 115 | 0.170 |
Why?
|
Entorhinal Cortex | 2 | 2023 | 286 | 0.170 |
Why?
|
Splenomegaly | 1 | 2020 | 189 | 0.170 |
Why?
|
Protein Precursors | 1 | 2024 | 1133 | 0.170 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2020 | 107 | 0.170 |
Why?
|
Infrared Rays | 2 | 2018 | 245 | 0.170 |
Why?
|
Anxiety | 6 | 2023 | 4533 | 0.170 |
Why?
|
Apolipoprotein E4 | 5 | 2021 | 706 | 0.160 |
Why?
|
Dermatologic Agents | 1 | 2023 | 308 | 0.160 |
Why?
|
Peptide Fragments | 4 | 2014 | 5098 | 0.160 |
Why?
|
Delirium | 2 | 2021 | 1663 | 0.160 |
Why?
|
Neurofilament Proteins | 1 | 2021 | 333 | 0.160 |
Why?
|
Cardiopulmonary Bypass | 2 | 2021 | 1093 | 0.160 |
Why?
|
Adjuvants, Immunologic | 3 | 2018 | 1036 | 0.160 |
Why?
|
Foramen Ovale, Patent | 1 | 2021 | 208 | 0.160 |
Why?
|
Aniline Compounds | 8 | 2017 | 1068 | 0.150 |
Why?
|
Neurodegenerative Diseases | 2 | 2023 | 1081 | 0.150 |
Why?
|
Radius Fractures | 1 | 2024 | 513 | 0.150 |
Why?
|
Acne Vulgaris | 1 | 2023 | 356 | 0.150 |
Why?
|
Clinical Chemistry Tests | 1 | 2018 | 59 | 0.150 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2021 | 597 | 0.150 |
Why?
|
Kidney Calculi | 1 | 2022 | 463 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 13 | 2024 | 36271 | 0.150 |
Why?
|
Brain Ischemia | 2 | 2021 | 3047 | 0.150 |
Why?
|
Vision, Ocular | 1 | 2021 | 454 | 0.150 |
Why?
|
Ischemic Attack, Transient | 1 | 2023 | 878 | 0.140 |
Why?
|
Autistic Disorder | 6 | 1992 | 1216 | 0.140 |
Why?
|
Electroencephalography | 6 | 2023 | 6187 | 0.140 |
Why?
|
Ribonucleoproteins | 1 | 2019 | 372 | 0.140 |
Why?
|
Alopecia Areata | 1 | 2019 | 127 | 0.140 |
Why?
|
Pregnancy Trimester, Third | 1 | 2019 | 582 | 0.140 |
Why?
|
Epilepsy | 2 | 2023 | 3270 | 0.130 |
Why?
|
Thiazoles | 8 | 2017 | 1511 | 0.130 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2017 | 213 | 0.130 |
Why?
|
C-Reactive Protein | 1 | 2008 | 3811 | 0.130 |
Why?
|
Prospective Studies | 15 | 2024 | 54108 | 0.130 |
Why?
|
Hot Flashes | 1 | 2019 | 328 | 0.130 |
Why?
|
Nerve Degeneration | 3 | 2011 | 748 | 0.130 |
Why?
|
Gaucher Disease | 1 | 2016 | 110 | 0.130 |
Why?
|
Dyskinesia, Drug-Induced | 3 | 1991 | 165 | 0.130 |
Why?
|
Child Health Services | 1 | 2021 | 644 | 0.130 |
Why?
|
Tropanes | 1 | 2015 | 48 | 0.130 |
Why?
|
Celiac Disease | 1 | 2024 | 822 | 0.130 |
Why?
|
Psychomotor Performance | 3 | 2019 | 1878 | 0.130 |
Why?
|
Telephone | 1 | 2019 | 625 | 0.120 |
Why?
|
Diabetes, Gestational | 2 | 2022 | 1241 | 0.120 |
Why?
|
Cardiac Surgical Procedures | 2 | 2020 | 3603 | 0.120 |
Why?
|
Motor Activity | 2 | 2015 | 2686 | 0.120 |
Why?
|
Pregnancy Trimester, First | 1 | 2019 | 906 | 0.120 |
Why?
|
Respiratory Mechanics | 1 | 2019 | 699 | 0.120 |
Why?
|
Hydrocephalus | 1 | 2021 | 763 | 0.120 |
Why?
|
Lymphedema | 1 | 2021 | 524 | 0.120 |
Why?
|
Ketamine | 1 | 2020 | 516 | 0.120 |
Why?
|
Radionuclide Imaging | 2 | 2015 | 1976 | 0.120 |
Why?
|
Low Back Pain | 1 | 2023 | 979 | 0.120 |
Why?
|
Parietal Lobe | 2 | 2017 | 849 | 0.110 |
Why?
|
Glucose Tolerance Test | 3 | 2022 | 1173 | 0.110 |
Why?
|
Affect | 1 | 2021 | 1480 | 0.110 |
Why?
|
Quantitative Trait Loci | 2 | 2020 | 2100 | 0.110 |
Why?
|
Awareness | 1 | 2018 | 644 | 0.110 |
Why?
|
Schools, Medical | 1 | 2020 | 877 | 0.110 |
Why?
|
Hallucinations | 2 | 2013 | 366 | 0.110 |
Why?
|
Analgesics | 1 | 2020 | 1064 | 0.110 |
Why?
|
Amyloid | 2 | 2023 | 840 | 0.110 |
Why?
|
Rectal Neoplasms | 1 | 2022 | 1154 | 0.110 |
Why?
|
Blood Transfusion | 1 | 2020 | 1295 | 0.110 |
Why?
|
Environment Design | 1 | 2015 | 172 | 0.110 |
Why?
|
Vision Disorders | 1 | 2020 | 1084 | 0.110 |
Why?
|
Gene Expression Regulation | 4 | 2018 | 11893 | 0.110 |
Why?
|
Multifactorial Inheritance | 1 | 2021 | 1365 | 0.110 |
Why?
|
Severity of Illness Index | 9 | 2020 | 15782 | 0.110 |
Why?
|
Follow-Up Studies | 10 | 2021 | 39018 | 0.100 |
Why?
|
Disability Evaluation | 2 | 2018 | 1825 | 0.100 |
Why?
|
Neocortex | 1 | 2016 | 416 | 0.100 |
Why?
|
Microarray Analysis | 1 | 2015 | 745 | 0.100 |
Why?
|
Patient Preference | 1 | 2020 | 917 | 0.100 |
Why?
|
Staphylococcal Infections | 1 | 2021 | 1406 | 0.100 |
Why?
|
Mental Status Schedule | 2 | 2014 | 314 | 0.100 |
Why?
|
Faculty, Medical | 1 | 2020 | 1192 | 0.100 |
Why?
|
Anemia, Sickle Cell | 1 | 2020 | 1053 | 0.100 |
Why?
|
Genetic Loci | 1 | 2021 | 2612 | 0.100 |
Why?
|
Laser Therapy | 1 | 2018 | 1082 | 0.100 |
Why?
|
Synapses | 1 | 2021 | 1757 | 0.100 |
Why?
|
Mast Cells | 1 | 2018 | 1390 | 0.100 |
Why?
|
Neural Pathways | 2 | 2021 | 3040 | 0.090 |
Why?
|
Seizures | 2 | 2023 | 2919 | 0.090 |
Why?
|
Temporal Lobe | 3 | 2017 | 1688 | 0.090 |
Why?
|
Atrophy | 2 | 2023 | 1627 | 0.090 |
Why?
|
Lung Diseases, Interstitial | 1 | 2019 | 910 | 0.090 |
Why?
|
Autoantibodies | 1 | 2019 | 2118 | 0.090 |
Why?
|
Amyloidogenic Proteins | 2 | 2023 | 151 | 0.090 |
Why?
|
Insulin Resistance | 2 | 2022 | 3941 | 0.090 |
Why?
|
Hematopoiesis | 1 | 2020 | 2047 | 0.090 |
Why?
|
Radiopharmaceuticals | 3 | 2017 | 2634 | 0.090 |
Why?
|
Adult | 24 | 2024 | 219747 | 0.090 |
Why?
|
Contrast Media | 1 | 2024 | 5297 | 0.090 |
Why?
|
Retrospective Studies | 14 | 2024 | 79982 | 0.090 |
Why?
|
Homocysteine | 2 | 2021 | 638 | 0.090 |
Why?
|
Pain Measurement | 1 | 2020 | 3523 | 0.090 |
Why?
|
Blood Glucose | 2 | 2022 | 6349 | 0.090 |
Why?
|
Haloperidol | 2 | 1991 | 388 | 0.090 |
Why?
|
Bone Marrow | 1 | 2020 | 2910 | 0.090 |
Why?
|
Students, Medical | 1 | 2023 | 1926 | 0.090 |
Why?
|
Influenza Vaccines | 1 | 2017 | 759 | 0.090 |
Why?
|
Neovascularization, Pathologic | 1 | 2020 | 2638 | 0.080 |
Why?
|
Health Promotion | 2 | 2021 | 2202 | 0.080 |
Why?
|
Immunoassay | 1 | 2013 | 746 | 0.080 |
Why?
|
Multiple System Atrophy | 1 | 2011 | 129 | 0.080 |
Why?
|
Personality Assessment | 1 | 1991 | 650 | 0.080 |
Why?
|
Apolipoproteins E | 4 | 2003 | 1436 | 0.080 |
Why?
|
Amyloid beta-Protein Precursor | 3 | 2013 | 1110 | 0.080 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2017 | 2004 | 0.080 |
Why?
|
Health Behavior | 2 | 2018 | 2615 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2019 | 3208 | 0.080 |
Why?
|
Psychotic Disorders | 1 | 2023 | 3197 | 0.080 |
Why?
|
Vaccination | 2 | 2018 | 3356 | 0.080 |
Why?
|
Disabled Persons | 1 | 2018 | 1224 | 0.080 |
Why?
|
Insulin | 2 | 2022 | 6578 | 0.080 |
Why?
|
Kidney | 1 | 2024 | 7013 | 0.080 |
Why?
|
Injections, Intradermal | 2 | 2018 | 116 | 0.080 |
Why?
|
Liver | 1 | 2024 | 7503 | 0.080 |
Why?
|
Patient Compliance | 1 | 2018 | 2685 | 0.070 |
Why?
|
Simvastatin | 1 | 2010 | 351 | 0.070 |
Why?
|
Respiration, Artificial | 1 | 2019 | 2619 | 0.070 |
Why?
|
Cohort Studies | 9 | 2024 | 41198 | 0.070 |
Why?
|
Memantine | 1 | 2008 | 107 | 0.070 |
Why?
|
Dopamine Agents | 1 | 2008 | 189 | 0.070 |
Why?
|
Genome-Wide Association Study | 2 | 2021 | 12604 | 0.070 |
Why?
|
Sleep | 1 | 2023 | 4745 | 0.070 |
Why?
|
Age of Onset | 4 | 2015 | 3296 | 0.070 |
Why?
|
Pneumonia | 1 | 2019 | 2127 | 0.070 |
Why?
|
Body Weight | 1 | 2018 | 4602 | 0.070 |
Why?
|
Alleles | 3 | 2016 | 6894 | 0.070 |
Why?
|
Sex Factors | 5 | 2020 | 10497 | 0.070 |
Why?
|
Body Mass Index | 3 | 2021 | 12870 | 0.070 |
Why?
|
RNA, Messenger | 3 | 2015 | 12761 | 0.070 |
Why?
|
Heat-Shock Proteins | 1 | 2010 | 795 | 0.070 |
Why?
|
Child | 14 | 2024 | 79787 | 0.070 |
Why?
|
Cholinesterase Inhibitors | 1 | 2008 | 239 | 0.070 |
Why?
|
Vascular Diseases | 1 | 2015 | 1160 | 0.070 |
Why?
|
Organ Size | 1 | 2011 | 2248 | 0.070 |
Why?
|
Histones | 2 | 2017 | 2577 | 0.060 |
Why?
|
Plaque, Amyloid | 1 | 2010 | 758 | 0.060 |
Why?
|
Early Diagnosis | 1 | 2010 | 1177 | 0.060 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2007 | 296 | 0.060 |
Why?
|
Morbidity | 2 | 2021 | 1748 | 0.060 |
Why?
|
Proportional Hazards Models | 5 | 2021 | 12400 | 0.060 |
Why?
|
Lipids | 1 | 2016 | 3326 | 0.060 |
Why?
|
Pregnancy Complications | 1 | 2019 | 2942 | 0.060 |
Why?
|
Huntington Disease | 1 | 2011 | 1141 | 0.060 |
Why?
|
Patient Readmission | 1 | 2018 | 3241 | 0.060 |
Why?
|
Age Factors | 6 | 2019 | 18328 | 0.060 |
Why?
|
Neurologic Examination | 2 | 2020 | 915 | 0.060 |
Why?
|
Life Style | 1 | 2015 | 3886 | 0.050 |
Why?
|
Thiosulfates | 1 | 2023 | 53 | 0.050 |
Why?
|
Speech Discrimination Tests | 1 | 2003 | 35 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20499 | 0.050 |
Why?
|
Memory Disorders | 5 | 2011 | 1198 | 0.050 |
Why?
|
Genetic Variation | 1 | 2018 | 6549 | 0.050 |
Why?
|
Mental Recall | 2 | 2023 | 1209 | 0.050 |
Why?
|
Mice, Inbred C57BL | 7 | 2024 | 22008 | 0.050 |
Why?
|
Internship and Residency | 1 | 2023 | 5854 | 0.050 |
Why?
|
Reproducibility of Results | 7 | 2018 | 20039 | 0.050 |
Why?
|
Bipolar Disorder | 1 | 2020 | 5083 | 0.050 |
Why?
|
Prognosis | 6 | 2022 | 29493 | 0.050 |
Why?
|
Mice | 11 | 2024 | 81107 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 6841 | 0.050 |
Why?
|
Amnesia | 1 | 2004 | 255 | 0.050 |
Why?
|
Executive Function | 1 | 2011 | 1375 | 0.050 |
Why?
|
Quality of Life | 2 | 2021 | 13265 | 0.050 |
Why?
|
Friends | 1 | 2023 | 150 | 0.050 |
Why?
|
Genetic Testing | 1 | 2015 | 3529 | 0.050 |
Why?
|
Registries | 1 | 2018 | 8164 | 0.050 |
Why?
|
Isotretinoin | 1 | 2023 | 132 | 0.050 |
Why?
|
Shoulder | 1 | 2024 | 299 | 0.050 |
Why?
|
Problem Solving | 1 | 2004 | 440 | 0.050 |
Why?
|
Minocycline | 1 | 2023 | 168 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2020 | 5105 | 0.050 |
Why?
|
Proxy | 1 | 2022 | 148 | 0.050 |
Why?
|
Florida | 1 | 2023 | 428 | 0.050 |
Why?
|
Verbal Learning | 3 | 2014 | 463 | 0.050 |
Why?
|
Weaning | 1 | 2021 | 103 | 0.050 |
Why?
|
Follicular Phase | 1 | 2021 | 143 | 0.050 |
Why?
|
Time Factors | 7 | 2023 | 39815 | 0.050 |
Why?
|
Pilot Projects | 4 | 2019 | 8551 | 0.050 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2022 | 172 | 0.050 |
Why?
|
Enhancer Elements, Genetic | 2 | 2018 | 1356 | 0.050 |
Why?
|
Discrimination Learning | 1 | 2003 | 278 | 0.050 |
Why?
|
Predictive Value of Tests | 6 | 2018 | 15209 | 0.050 |
Why?
|
Cholesterol | 1 | 2010 | 2900 | 0.050 |
Why?
|
Analysis of Variance | 2 | 1997 | 6231 | 0.050 |
Why?
|
Receptors, GABA | 1 | 2023 | 305 | 0.050 |
Why?
|
Bone Plates | 1 | 2024 | 465 | 0.050 |
Why?
|
Gene Expression | 4 | 2011 | 7584 | 0.050 |
Why?
|
Animals | 13 | 2024 | 167777 | 0.040 |
Why?
|
Semantics | 1 | 2004 | 601 | 0.040 |
Why?
|
Survival Analysis | 3 | 2021 | 10075 | 0.040 |
Why?
|
Cyclothymic Disorder | 1 | 2020 | 42 | 0.040 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2021 | 186 | 0.040 |
Why?
|
Infarction | 1 | 2021 | 247 | 0.040 |
Why?
|
Receptors, Glutamate | 1 | 2001 | 228 | 0.040 |
Why?
|
Spin Labels | 1 | 2021 | 336 | 0.040 |
Why?
|
Artifacts | 1 | 2008 | 1894 | 0.040 |
Why?
|
Pregnancy | 4 | 2023 | 29720 | 0.040 |
Why?
|
Technology | 1 | 2022 | 292 | 0.040 |
Why?
|
Mutation | 3 | 2021 | 29928 | 0.040 |
Why?
|
Regression Analysis | 3 | 2009 | 6336 | 0.040 |
Why?
|
Case-Control Studies | 6 | 2020 | 22024 | 0.040 |
Why?
|
Cellulitis | 1 | 2021 | 207 | 0.040 |
Why?
|
Pick Disease of the Brain | 1 | 2000 | 42 | 0.040 |
Why?
|
Double-Blind Method | 5 | 2023 | 12260 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2011 | 3338 | 0.040 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2001 | 311 | 0.040 |
Why?
|
Linear Models | 3 | 2014 | 5857 | 0.040 |
Why?
|
Adolescent | 8 | 2019 | 87832 | 0.040 |
Why?
|
Levodopa | 2 | 2012 | 218 | 0.040 |
Why?
|
Heart Failure | 1 | 2023 | 11593 | 0.040 |
Why?
|
Mental Disorders | 1 | 2018 | 6802 | 0.040 |
Why?
|
Hand | 1 | 2024 | 902 | 0.040 |
Why?
|
Exercise | 1 | 2015 | 5788 | 0.040 |
Why?
|
Area Under Curve | 1 | 2022 | 1632 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2020 | 4342 | 0.040 |
Why?
|
Career Mobility | 1 | 2020 | 258 | 0.040 |
Why?
|
Adrenergic beta-1 Receptor Agonists | 1 | 2017 | 14 | 0.040 |
Why?
|
Social Isolation | 1 | 2021 | 362 | 0.040 |
Why?
|
Poverty | 2 | 2021 | 2688 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2024 | 18123 | 0.040 |
Why?
|
Agnosia | 1 | 2018 | 66 | 0.040 |
Why?
|
Abscess | 1 | 2021 | 605 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1702 | 0.040 |
Why?
|
Cartilage | 1 | 2021 | 806 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2023 | 856 | 0.040 |
Why?
|
Range of Motion, Articular | 1 | 2024 | 1583 | 0.040 |
Why?
|
Fracture Fixation, Internal | 1 | 2024 | 963 | 0.040 |
Why?
|
Mannose-Binding Lectins | 1 | 2017 | 96 | 0.040 |
Why?
|
Pancreas | 1 | 2024 | 1676 | 0.030 |
Why?
|
Perfusion | 1 | 2021 | 1374 | 0.030 |
Why?
|
Introns | 1 | 1999 | 978 | 0.030 |
Why?
|
Albuterol | 1 | 2017 | 212 | 0.030 |
Why?
|
Treatment Outcome | 5 | 2024 | 64242 | 0.030 |
Why?
|
Memory, Short-Term | 1 | 2003 | 980 | 0.030 |
Why?
|
Child Behavior Disorders | 2 | 1992 | 805 | 0.030 |
Why?
|
Haplotypes | 1 | 2023 | 2764 | 0.030 |
Why?
|
Glasgow Coma Scale | 1 | 2018 | 579 | 0.030 |
Why?
|
Receptors, CCR2 | 1 | 2017 | 215 | 0.030 |
Why?
|
Hyperinsulinism | 1 | 2019 | 400 | 0.030 |
Why?
|
Norway | 1 | 2017 | 496 | 0.030 |
Why?
|
Uric Acid | 1 | 2022 | 803 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2021 | 1065 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2018 | 18941 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2018 | 877 | 0.030 |
Why?
|
ROC Curve | 2 | 2014 | 3562 | 0.030 |
Why?
|
Association Learning | 1 | 1997 | 221 | 0.030 |
Why?
|
Cell Movement | 2 | 2018 | 5201 | 0.030 |
Why?
|
Massachusetts | 3 | 2015 | 8815 | 0.030 |
Why?
|
Propranolol | 1 | 2017 | 489 | 0.030 |
Why?
|
Ethylene Glycols | 1 | 2017 | 190 | 0.030 |
Why?
|
Drainage | 1 | 2021 | 1156 | 0.030 |
Why?
|
Substantia Nigra | 1 | 2017 | 350 | 0.030 |
Why?
|
Psychiatry | 1 | 1988 | 1690 | 0.030 |
Why?
|
Spatial Behavior | 1 | 1995 | 88 | 0.030 |
Why?
|
Educational Status | 1 | 2003 | 2511 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 4047 | 0.030 |
Why?
|
Independent Living | 1 | 2019 | 567 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1611 | 0.030 |
Why?
|
Risk Factors | 7 | 2021 | 73716 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2018 | 1032 | 0.030 |
Why?
|
Acetylation | 1 | 2017 | 1060 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2011 | 8945 | 0.030 |
Why?
|
Neurons | 3 | 2010 | 9419 | 0.030 |
Why?
|
Immunization | 1 | 2018 | 1227 | 0.030 |
Why?
|
Space Perception | 1 | 1997 | 464 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2022 | 3595 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2024 | 7401 | 0.030 |
Why?
|
Cytokines | 2 | 2019 | 7339 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2017 | 585 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2019 | 1680 | 0.030 |
Why?
|
India | 1 | 2020 | 2328 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2189 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2021 | 20999 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2018 | 727 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2015 | 6469 | 0.030 |
Why?
|
Risk | 2 | 2017 | 9590 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2022 | 2509 | 0.030 |
Why?
|
Mice, Hairless | 1 | 1993 | 39 | 0.030 |
Why?
|
Diagnosis, Differential | 4 | 2015 | 12950 | 0.030 |
Why?
|
Algorithms | 2 | 2017 | 13952 | 0.030 |
Why?
|
Genotype | 4 | 2016 | 12951 | 0.030 |
Why?
|
Cerebral Hemorrhage | 1 | 2005 | 2650 | 0.030 |
Why?
|
Antigens, Surface | 1 | 2017 | 1607 | 0.030 |
Why?
|
Minority Groups | 1 | 2020 | 1201 | 0.030 |
Why?
|
Physical Examination | 1 | 2019 | 1244 | 0.030 |
Why?
|
Family Health | 1 | 2018 | 1256 | 0.030 |
Why?
|
Geographic Information Systems | 1 | 2015 | 281 | 0.030 |
Why?
|
Hair Diseases | 1 | 1993 | 72 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2014 | 14638 | 0.030 |
Why?
|
Young Adult | 4 | 2020 | 58764 | 0.030 |
Why?
|
Cerebrovascular Circulation | 1 | 2023 | 2724 | 0.030 |
Why?
|
Administration, Oral | 1 | 2020 | 3995 | 0.030 |
Why?
|
Pimozide | 1 | 1992 | 21 | 0.030 |
Why?
|
Depressive Disorder, Major | 1 | 2010 | 4744 | 0.030 |
Why?
|
Patient Admission | 1 | 2019 | 1366 | 0.030 |
Why?
|
Diagnostic Self Evaluation | 1 | 2014 | 225 | 0.020 |
Why?
|
Apolipoprotein E3 | 1 | 2012 | 107 | 0.020 |
Why?
|
Warfarin | 1 | 2020 | 1483 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2017 | 1240 | 0.020 |
Why?
|
Carbon Radioisotopes | 1 | 2012 | 557 | 0.020 |
Why?
|
Incidence | 2 | 2021 | 21217 | 0.020 |
Why?
|
Antiparkinson Agents | 1 | 2012 | 184 | 0.020 |
Why?
|
Psychometrics | 1 | 2021 | 3050 | 0.020 |
Why?
|
Leptin | 1 | 2019 | 1591 | 0.020 |
Why?
|
Actigraphy | 1 | 2015 | 518 | 0.020 |
Why?
|
Visual Acuity | 1 | 2020 | 2642 | 0.020 |
Why?
|
Child, Preschool | 8 | 2024 | 42044 | 0.020 |
Why?
|
Carbamazepine | 1 | 1992 | 224 | 0.020 |
Why?
|
Mice, Inbred CBA | 1 | 2011 | 436 | 0.020 |
Why?
|
Transcription Factors | 1 | 2010 | 12092 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2020 | 2717 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2017 | 956 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2018 | 2129 | 0.020 |
Why?
|
Hydroxycholesterols | 1 | 2010 | 25 | 0.020 |
Why?
|
Ligands | 1 | 2017 | 3258 | 0.020 |
Why?
|
Bacteria | 1 | 2021 | 2198 | 0.020 |
Why?
|
Cocaine | 1 | 2015 | 958 | 0.020 |
Why?
|
Prevalence | 3 | 2013 | 15641 | 0.020 |
Why?
|
Reference Values | 2 | 2010 | 4918 | 0.020 |
Why?
|
Delusions | 1 | 2012 | 298 | 0.020 |
Why?
|
Weight Loss | 1 | 2021 | 2671 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2021 | 2782 | 0.020 |
Why?
|
HIV Infections | 1 | 2016 | 17275 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2017 | 5779 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3428 | 0.020 |
Why?
|
Mitochondria | 1 | 2023 | 3584 | 0.020 |
Why?
|
Stereotyped Behavior | 1 | 1990 | 135 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2016 | 1788 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3839 | 0.020 |
Why?
|
Benzothiazoles | 1 | 2010 | 246 | 0.020 |
Why?
|
Logistic Models | 2 | 2014 | 13222 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 1999 | 4283 | 0.020 |
Why?
|
Decision Making | 1 | 2022 | 3909 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 3800 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2022 | 11065 | 0.020 |
Why?
|
Mice, Transgenic | 3 | 2011 | 9519 | 0.020 |
Why?
|
Infant | 4 | 2024 | 36043 | 0.020 |
Why?
|
Perception | 1 | 2015 | 1194 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2013 | 979 | 0.020 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2016 | 1895 | 0.020 |
Why?
|
Length of Stay | 1 | 2021 | 6384 | 0.020 |
Why?
|
Lithium | 1 | 1991 | 596 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3861 | 0.020 |
Why?
|
Naltrexone | 1 | 1990 | 317 | 0.020 |
Why?
|
Visual Perception | 1 | 1995 | 1374 | 0.020 |
Why?
|
Zebrafish | 1 | 2018 | 2992 | 0.020 |
Why?
|
Aggression | 1 | 1992 | 746 | 0.020 |
Why?
|
In Situ Hybridization | 2 | 2001 | 1900 | 0.020 |
Why?
|
Imipramine | 1 | 1986 | 98 | 0.020 |
Why?
|
United States | 3 | 2020 | 71907 | 0.020 |
Why?
|
Time | 1 | 2008 | 543 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2011 | 772 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2018 | 3047 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2019 | 3732 | 0.020 |
Why?
|
Schools | 1 | 2015 | 1482 | 0.020 |
Why?
|
Dendrites | 1 | 2008 | 474 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12047 | 0.020 |
Why?
|
Selection Bias | 1 | 2007 | 357 | 0.020 |
Why?
|
Cerebral Amyloid Angiopathy | 2 | 2005 | 892 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 1988 | 999 | 0.020 |
Why?
|
Frontal Lobe | 1 | 2011 | 1419 | 0.020 |
Why?
|
Anticoagulants | 1 | 2020 | 4776 | 0.020 |
Why?
|
Cell Count | 1 | 2008 | 1835 | 0.010 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2007 | 397 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2008 | 2263 | 0.010 |
Why?
|
Medicaid | 1 | 2018 | 2794 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2010 | 1737 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2017 | 7590 | 0.010 |
Why?
|
Hypercholesterolemia | 1 | 2010 | 1139 | 0.010 |
Why?
|
Dopamine | 1 | 2010 | 1599 | 0.010 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2010 | 1988 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8601 | 0.010 |
Why?
|
Anticholesteremic Agents | 1 | 2010 | 963 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7982 | 0.010 |
Why?
|
Vitamin B 12 | 1 | 2005 | 523 | 0.010 |
Why?
|
Phosphorylation | 1 | 2013 | 8298 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7801 | 0.010 |
Why?
|
Movement | 1 | 2008 | 1474 | 0.010 |
Why?
|
Cholinesterases | 1 | 2001 | 32 | 0.010 |
Why?
|
Primary Health Care | 1 | 2018 | 4651 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 16891 | 0.010 |
Why?
|
Receptors, Purinergic P1 | 1 | 2001 | 108 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2008 | 17617 | 0.010 |
Why?
|
Receptors, Muscarinic | 1 | 2001 | 157 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2011 | 5195 | 0.010 |
Why?
|
Autoradiography | 1 | 2001 | 730 | 0.010 |
Why?
|
Receptors, Dopamine | 1 | 2001 | 293 | 0.010 |
Why?
|
Creatinine | 1 | 2005 | 1892 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 2001 | 622 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2018 | 5325 | 0.010 |
Why?
|
Oxygen | 1 | 2011 | 4190 | 0.010 |
Why?
|
Receptors, AMPA | 1 | 2001 | 322 | 0.010 |
Why?
|
Causality | 1 | 2005 | 1241 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17767 | 0.010 |
Why?
|
Reading | 1 | 2003 | 529 | 0.010 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 2001 | 195 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 1991 | 8515 | 0.010 |
Why?
|
Apolipoprotein E2 | 1 | 1999 | 135 | 0.010 |
Why?
|
Patient Selection | 1 | 2011 | 4235 | 0.010 |
Why?
|
Folic Acid | 1 | 2005 | 1309 | 0.010 |
Why?
|
Computational Biology | 1 | 2010 | 3501 | 0.010 |
Why?
|
Databases, Factual | 1 | 2014 | 7926 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 6293 | 0.010 |
Why?
|
Image Enhancement | 1 | 2008 | 2880 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 1991 | 3060 | 0.010 |
Why?
|
Endopeptidases | 1 | 2001 | 772 | 0.010 |
Why?
|
Obesity | 1 | 2019 | 12869 | 0.010 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2001 | 620 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2008 | 13447 | 0.010 |
Why?
|
Blood Platelets | 1 | 1986 | 2475 | 0.010 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2001 | 892 | 0.010 |
Why?
|
Comorbidity | 1 | 2010 | 10478 | 0.010 |
Why?
|
Nurses | 1 | 2005 | 2467 | 0.010 |
Why?
|
DNA Primers | 1 | 1999 | 2816 | 0.010 |
Why?
|
Likelihood Functions | 1 | 1997 | 986 | 0.010 |
Why?
|
Genetic Linkage | 1 | 1999 | 2381 | 0.010 |
Why?
|
Task Performance and Analysis | 1 | 1997 | 759 | 0.010 |
Why?
|
Cerebellum | 1 | 2001 | 1497 | 0.010 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 1993 | 516 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4567 | 0.010 |
Why?
|
Rats | 1 | 2008 | 23681 | 0.010 |
Why?
|
Pattern Recognition, Visual | 1 | 1997 | 810 | 0.010 |
Why?
|
Ultrasonography | 1 | 2005 | 5951 | 0.010 |
Why?
|
Reaction Time | 1 | 1997 | 2076 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2007 | 9404 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1993 | 1351 | 0.010 |
Why?
|
Immunophenotyping | 1 | 1993 | 1871 | 0.000 |
Why?
|
Schizophrenia | 1 | 1986 | 6913 | 0.000 |
Why?
|
Immune System | 1 | 1993 | 796 | 0.000 |
Why?
|
DNA | 1 | 1999 | 7199 | 0.000 |
Why?
|
Base Sequence | 1 | 1996 | 12437 | 0.000 |
Why?
|
Macromolecular Substances | 1 | 1986 | 1433 | 0.000 |
Why?
|
Flow Cytometry | 1 | 1993 | 5864 | 0.000 |
Why?
|
Lymphocyte Activation | 1 | 1993 | 5490 | 0.000 |
Why?
|
Serotonin | 1 | 1986 | 1040 | 0.000 |
Why?
|
Kinetics | 1 | 1986 | 6371 | 0.000 |
Why?
|
Recurrence | 1 | 1991 | 8426 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 1993 | 10172 | 0.000 |
Why?
|
Chronic Disease | 1 | 1986 | 9265 | 0.000 |
Why?
|